Rational design of enzyme inhibitors as potential drugs to treat tuberculosis, malaria, African sleeping sickness, and Chagas disease.

Objectives

This project sets to make drug-like compounds for infectious diseases such as Chagas Disease, malaria and tuberculosis, based on rationally-designed compounds which target essential metabolic enzymes in these pathogens.